Inspire Medical Systems Inc (INSP) - Total Liabilities

Latest as of December 2025: $137.33 Million USD

Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has total liabilities worth $137.33 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Inspire Medical Systems Inc generate cash to assess how effectively this company generates cash.

Inspire Medical Systems Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Inspire Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Inspire Medical Systems Inc to evaluate the company's liquid asset resilience ratio.

Inspire Medical Systems Inc Competitors by Total Liabilities

The table below lists competitors of Inspire Medical Systems Inc ranked by their total liabilities.

Company Country Total Liabilities
Shaily Engineering Plastics Limited
NSE:SHAILY
India Rs4.19 Billion
Corporación Interamericana de Entretenimiento S.A.B. de C.V
MX:CIEB
Mexico MX$7.70 Billion
Capital Southwest Corporation
NASDAQ:CSWC
USA $1.12 Billion
Dynagreen Environmental Protection Group Co Ltd
SHG:601330
China CN¥13.19 Billion
China Yuchai International Limited
F:CYD
Germany €14.75 Billion
Wam Leaders Ltd
AU:WLE
Australia AU$101.76 Million
Tansun Technology Co Ltd
SHE:300872
China CN¥730.71 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Inspire Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Inspire Medical Systems Inc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.08 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Inspire Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Inspire Medical Systems Inc (2016–2025)

The table below shows the annual total liabilities of Inspire Medical Systems Inc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 $126.16 Million +6.29%
2024-12-31 $118.69 Million +13.80%
2023-12-31 $104.30 Million +51.44%
2022-12-31 $68.87 Million +4.29%
2021-12-31 $66.04 Million +28.37%
2020-12-31 $51.44 Million +24.20%
2019-12-31 $41.42 Million +14.79%
2018-12-31 $36.08 Million +52.84%
2017-12-31 $23.61 Million +19.69%
2016-12-31 $19.72 Million --

About Inspire Medical Systems Inc

NYSE:INSP USA Medical Devices
Market Cap
$1.31 Billion
Market Cap Rank
#8007 Global
#2214 in USA
Share Price
$45.70
Change (1 day)
-5.28%
52-Week Range
$45.70 - $159.76
All Time High
$326.08
About

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more